Biofunctionalized liposomes to monitor rheumatoid arthritis regression stimulated by Interleukin-23 neutralization

Even after the revolution of rheumatoid arthritis (RA) treatment with biologic agents, this debilitating disease remains a major clinical problem. The outstanding outcomes of the systemic administration of antibodies (Abs) are narrowed by the risk of serious side effects and limited efficacy due to...

Ausführliche Beschreibung